Hard To Treat Stock Analysis
Below is the normalized historical share price chart for Hard to Treat extending back to September 23, 1998. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions.
Total Stockholder Equity is likely to gain to about 2.1 M in 2026, whereas Other Stockholder Equity is likely to drop (299.8 K) in 2026. .
Beta 0.416 |
Hard to Treat holds a debt-to-equity ratio of 0.206. Long Term Debt is likely to drop to about 64.9 K in 2026. Short and Long Term Debt is likely to drop to about 1 M in 2026 Hard To's financial risk is the risk to Hard To stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Hard To's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Hard To's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Hard Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Hard To's stakeholders.
For many companies, including Hard To, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Hard to Treat, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Hard To's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Enterprise Value 254.4 K | Price Sales 0.0178 | Shares Outstanding | Market Capitalization 109.6 K | Revenue Per Share 0.001 |
Hard to Treat is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Hard To stock analysis is to determine its intrinsic value, which is an estimate of what Hard to Treat is worth, separate from its market price. There are two main types of Hard To's stock analysis: fundamental analysis and technical analysis.
The Hard To stock is traded in the USA on OTCCE Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Hard To is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Hard Stock trading window is adjusted to America/New York timezone.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hard to Treat. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. Hard Stock Analysis Notes
The company had not issued any dividends in recent years. Hard to Treat Diseases Inc. manufactures, supplies, and exports biopharmaceuticals and vaccines in China and internationally. Hard to Treat Diseases Inc. was founded in 2009 and is based in Shenzhen, China. Hard To operates under Biotechnology classification in the United States and is traded on OTC Exchange. To learn more about Hard to Treat call the company at 86 755 8272 0498 or check out https://www.mellowhope.com.Hard To Quarterly Total Revenue |
|
Hard to Treat Investment Alerts
| Hard to Treat generated a negative expected return over the last 90 days | |
| Hard to Treat has some characteristics of a very speculative penny stock | |
| Hard to Treat has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Tildrakizumab Shows Long-Term Psoriasis Control for Hard-to-Treat Areas - American Journal of Managed Care |
Hard Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 109.65 K.Hard Profitablity
The company has Profit Margin (PM) of 0.16 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.17 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.17.Management Efficiency
Net Tangible Assets is likely to gain to about 2.1 M in 2026, whereas Total Assets are likely to drop slightly above 2.9 M in 2026. Hard To's management efficiency ratios could be used to measure how well Hard To manages its routine affairs as well as how well it operates its assets and liabilities.Management at Hard to Treat focuses on leveraging technology and optimizing operations. We evaluate the impact of these focuses on the company's financial health and stock performance.
Technical Drivers
Hard To technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Hard to Treat Price Movement Analysis
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Moving Average is predictive technique used to analyze Hard to Treat price data points by creating a series of averages of different subsets of Hard To entire price series.
Hard To Outstanding Bonds
Hard To issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Hard to Treat uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Hard bonds can be classified according to their maturity, which is the date when Hard to Treat has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Hard To Bond Ratings
Hard to Treat financial ratings play a critical role in determining how much Hard To have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Hard To's borrowing costs.| Piotroski F Score | 2 | Frail | View |
| Beneish M Score | (3.58) | Unlikely Manipulator | View |
Hard to Treat Debt to Cash Allocation
Many companies such as Hard To, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Hard to Treat currently holds 1.54 M in liabilities with Debt to Equity (D/E) ratio of 0.21, which may suggest the company is not taking enough advantage from borrowing. Hard to Treat has a current ratio of 2.22, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Hard To's use of debt, we should always consider it together with its cash and equity.Hard To Total Assets Over Time
Hard To Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Hard To's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Hard To, which in turn will lower the firm's financial flexibility.Hard To Corporate Bonds Issued
About Hard Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Hard To prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Hard shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Hard To. By using and applying Hard Stock analysis, traders can create a robust methodology for identifying Hard entry and exit points for their positions.
Hard to Treat Diseases Inc. manufactures, supplies, and exports biopharmaceuticals and vaccines in China and internationally. Hard to Treat Diseases Inc. was founded in 2009 and is based in Shenzhen, China. Hard To operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Hard To to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
Additional Tools for Hard Stock Analysis
When running Hard To's price analysis, check to measure Hard To's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hard To is operating at the current time. Most of Hard To's value examination focuses on studying past and present price action to predict the probability of Hard To's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hard To's price. Additionally, you may evaluate how the addition of Hard To to your portfolios can decrease your overall portfolio volatility.